journal article·2026-04-01Open access

Spatially Organized DNA-Templated Silver Nanoclusters as Potent Antimicrobial Agents for ESKAPE Infections

Elizabeth Skelly, Krishna Majithia, Laura P. Rebolledo, Camila Fonseca Rizek, Silvia Figueiredo Costa, Alora R. Dunnavant, Cheyenne Vasquez, Alexander J. Lushnikov, Alexey V. Krasnoslobodtsev, Taejin Kim, Morgan R. Chandler, Renata de Freitas Saito, Roger Chammas, M. Brittany Johnson, Kirill A. Afonin

ACS Applied Materials & Interfaces· Volume 18· Issue 12

Abstract

High Resolution Image Download MS PowerPoint Slide Antibiotic-resistant bacteria cause more than one million deaths annually worldwide. The rapid evolution and horizontal gene transfer among pathogens frequently render newly developed antibiotics ineffective shortly after their introduction, underscoring the urgent need for alternative therapeutic strategies. Nanoscale silver is well known for its innate antimicrobial activity but typically requires high concentrations for efficacy that causes toxicities and limits broader clinical applications. To overcome these limitations, we introduce programmable, self-assembling DNA scaffolds that template, stabilize, and spatially organize multiple copies of monodisperse silver nanoclusters (DNA-AgNCs). These nanoscale assemblies enhance the antimicrobial potency of formulations while exhibiting intrinsic fluorescence, providing a dual functionality for therapeutic and fluorescence probing applications. Comprehensive characterization revealed DNA-AgNCs with superior stability and potent activity against clinically relevant antibiotic-resistant ESKAPE pathogens. Also, DNA-AgNCs significantly reduced the intracellular bacterial burden in primary murine bone cells infected with Staphylococcus aureus . Mechanistic studies indicate that bacterial killing by DNA-AgNCs is mediated by reactive oxygen species, particularly singlet oxygen, in conjunction with the disruption of the bacterial membrane. Furthermore, DNA-AgNCs retained strong antibacterial activity after 4 weeks of storage at ambient temperatures, with minimal loss of efficacy. Collectively, these findings establish spatially organized DNA-AgNCs as a promising, modular platform for next-generation antibacterials with integrated real-time fluorescence probing capabilities.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanocluster Synthesis and Applications · Gold and Silver Nanoparticles Synthesis and Applications · Quantum Dots Synthesis And Properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Chemistry and Nanoscale Science Program, Department of Chemistry

University of North Carolina at Charlotte

Department of Biology

Laboratório de Investigação Médica 49, Departamento de Infectologia e Medicina Tropical da Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Eneas de Carvalho Aguiar, 470, São Paulo 05403-000, Brazil

Centres for Antimicrobial Optimisation Network (CAMO-Net) Brazil, Faculty of Medicine

University of São Paulo

Department of Physics

University of Nebraska Omaha

Department of Physical Sciences

West Virginia University Institute of Technology

MIMETAS US, Inc

Centro de Investigação Translacional em Oncologia (LIM24), Departamento de Radiologia e Oncologia

Faculdade de Medicina da Universidade de São Paulo and Instituto do Câncer do Estado de São Paulo

Funding

National Institute of Allergy and Infectious Diseases · North Carolina Biotechnology Center · National Institute of General Medical Sciences

References (84)

Show source-provided references
1. 10.1038/nature1704210.1038/nature17042 ↗
2. Ventola C. L. · P t · 2015 · 40 · 277
3. 10.1016/S0140-6736(04)16727-510.1016/S0140-6736(04)16727-5 ↗
4. 10.3389/fimmu.2021.63808510.3389/fimmu.2021.638085 ↗
5. Hatzenbuehler J. · Am. Fam. Physician · 2011 · 84 · 1027
6. 10.1097/00006454-198801000-0000710.1097/00006454-198801000-00007 ↗
7. 10.1128/IAI.00932-1910.1128/IAI.00932-19 ↗
8. 10.1128/MMBR.00026-1910.1128/MMBR.00026-19 ↗
9. 10.4103/jgid.jgid_91_1610.4103/jgid.jgid_91_16 ↗
10. 10.1128/IAI.67.5.2677-2681.199910.1128/IAI.67.5.2677-2681.1999 ↗
11. 10.1128/mbio.02447-1910.1128/mbio.02447-19 ↗
12. 10.3389/fmicb.2022.93746610.3389/fmicb.2022.937466 ↗
13. 10.1016/S8756-3282(99)00239-210.1016/S8756-3282(99)00239-2 ↗
14. 10.3389/fcimb.2021.78102210.3389/fcimb.2021.781022 ↗
15. 10.3390/pathogens1008106410.3390/pathogens10081064 ↗
16. 10.1086/65604710.1086/656047 ↗
17. 10.1038/nrmicro138410.1038/nrmicro1384 ↗
18. 10.1128/IAI.67.5.2677-2681.199910.1128/IAI.67.5.2677-2681.1999 ↗
19. 10.3389/fcimb.2015.0008510.3389/fcimb.2015.00085 ↗
20. 10.1128/mBio.02447-1910.1128/mBio.02447-19 ↗
21. 10.1016/j.biotechadv.2018.05.00410.1016/j.biotechadv.2018.05.004 ↗
22. 10.1126/scitranslmed.300627610.1126/scitranslmed.3006276 ↗
23. 10.1016/j.nano.2017.06.01510.1016/j.nano.2017.06.015 ↗
24. 10.1038/s41579-020-0420-110.1038/s41579-020-0420-1 ↗
25. 10.1039/C3RA44507K10.1039/C3RA44507K ↗
26. 10.1016/j.msec.2018.12.10210.1016/j.msec.2018.12.102 ↗
27. 10.2147/IJN.S12195610.2147/IJN.S121956 ↗
28. 10.1016/j.tibtech.2010.07.00610.1016/j.tibtech.2010.07.006 ↗
29. 10.1021/acs.jchemed.3c0012510.1021/acs.jchemed.3c00125 ↗
30. 10.2217/nnm-2023-008210.2217/nnm-2023-0082 ↗
31. 10.3390/molecules2613404510.3390/molecules26134045 ↗
32. 10.1021/acsami.6b0067010.1021/acsami.6b00670 ↗
33. 10.1021/acsami.1c0575110.1021/acsami.1c05751 ↗
34. 10.1099/jmm.0.00117410.1099/jmm.0.001174 ↗
35. 10.1039/C6NR05872H10.1039/C6NR05872H ↗
36. 10.1007/978-1-0716-3417-2_2110.1007/978-1-0716-3417-2_21 ↗
37. 10.1039/D0NR03589K10.1039/D0NR03589K ↗
38. 10.3390/nano904061310.3390/nano9040613 ↗
39. 10.1021/jp064848710.1021/jp0648487 ↗
40. 10.1021/acs.analchem.8b0449310.1021/acs.analchem.8b04493 ↗
41. 10.1002/bio.447110.1002/bio.4471 ↗
42. 10.1039/D0QM00117A10.1039/D0QM00117A ↗
43. 10.3390/nano501018010.3390/nano5010180 ↗
44. 10.1021/acsabm.5c0125710.1021/acsabm.5c01257 ↗
45. 10.1007/978-1-0716-3417-2_1010.1007/978-1-0716-3417-2_10 ↗
46. 10.1002/adma.20120462410.1002/adma.201204624 ↗
47. 10.1021/jp809274m10.1021/jp809274m ↗
48. 10.1021/jz500146q10.1021/jz500146q ↗
49. 10.1002/sstr.20250002210.1002/sstr.202500022 ↗
50. 10.1007/978-1-4939-2562-9_410.1007/978-1-4939-2562-9_4 ↗
51. 10.1021/acs.jchemed.0c0015810.1021/acs.jchemed.0c00158 ↗
52. 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-310.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3 ↗
53. 10.3390/molecules2516363110.3390/molecules25163631 ↗
54. 10.1039/D4NR03429E10.1039/D4NR03429E ↗
55. 10.1021/acs.nanolett.4c0156110.1021/acs.nanolett.4c01561 ↗
56. 10.1016/j.talanta.2024.12583410.1016/j.talanta.2024.125834 ↗
57. 10.1039/D0NA01005G10.1039/D0NA01005G ↗
58. Drewa T. · Acta Polym. Pharm. · 2007 · 64 · 175
59. 10.1021/acsnanomed.5c0007010.1021/acsnanomed.5c00070 ↗
60. Centers for Disease Control and Prevention Antibiotic Resistance Threatsin the United States ; Department of Health and Human Services, CDC: Atlanta, GA, 2019.
61. World Health Organization (WHO) Antimicrobial Resistance Global Report on Surveillance ; World Health Organization (WHO): Geneva, Switzerland, 2014.
62. 10.1016/j.nano.2006.12.00110.1016/j.nano.2006.12.001 ↗
63. 10.1093/jac/dkae38010.1093/jac/dkae380 ↗
64. 10.3390/nano912177510.3390/nano9121775 ↗
65. 10.1016/j.mset.2020.09.00210.1016/j.mset.2020.09.002 ↗
66. 10.1080/15287394.2017.137672710.1080/15287394.2017.1376727 ↗
67. 10.1002/jat.365410.1002/jat.3654 ↗
68. 10.1089/bio.2015.002910.1089/bio.2015.0029 ↗
69. 10.1016/j.jconrel.2025.11425910.1016/j.jconrel.2025.114259 ↗
70. 10.3390/vaccines909103310.3390/vaccines9091033 ↗
71. 10.1016/S0304-3991(03)00053-610.1016/S0304-3991(03)00053-6 ↗
72. Lushnikov A. J. · 2023 · 19110.1007/978-1-0716-3417-2_12 ↗
73. 10.1023/A:101498753254610.1023/A:1014987532546 ↗
74. 10.1039/D3NA00092C10.1039/D3NA00092C ↗
75. 10.1021/acsomega.7b0108910.1021/acsomega.7b01089 ↗
76. Clinical & Laboratory Standards Institute Clinical and Laboratory Standards Institute Performace Standards for Antimicrobial Susceptibility Testing; twentieth-first Information Supplement ; Clinical & Laboratory Standards Institute: Wayne, PA, 2013.
77. 10.1128/mbio.03971-2410.1128/mbio.03971-24 ↗
78. 10.3389/fmicb.2022.106623710.3389/fmicb.2022.1066237 ↗
79. 10.1021/acs.jmedchem.4c0043610.1021/acs.jmedchem.4c00436 ↗
80. 10.1128/IAI.71.9.5418-5421.200310.1128/IAI.71.9.5418-5421.2003 ↗
81. 10.1128/iai.00014-2310.1128/iai.00014-23 ↗
82. 10.1089/10799900130017748410.1089/107999001300177484 ↗
83. 10.3389/fmicb.2022.106623710.3389/fmicb.2022.1066237 ↗
84. 10.1007/s10753-022-01731-z10.1007/s10753-022-01731-z ↗